Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Acclarent, a medical technology company, has obtained a new patent from the US Patent and Trademark Office. This patent and Acclarent's earlier patent are directed to methods for treating a paranasal sinus ostium, such as the maxillary sinus ostium, either through the nostril or other routes.
Subscribe to our email newsletter
The agreement provides Novotech with the rights to sell in most Middle Eastern countries, all North African countries, India, Pakistan and certain other Asian countries. Sales will be consummated primarily through specialty distributors; however, in certain instances, direct to hospital sales will be permitted. Minimum sales performance criteria are stipulated in the agreement.
Misonix is excited about Novotech Solutions joining our sales and distribution organization. Their past sales successes in this important part of the world are well known to us, said Michael A. McManus, president and chief executive officer of Misonix. Novotech’s reputation for establishing distributor sales and service organizations while complying with local regulatory issues will serve us well as our presence in this region expands. We are very pleased that they will be representing three of our product platforms to their well established distribution channels.